{"id":"NCT01378429","sponsor":"Sumitomo Pharma America, Inc.","briefTitle":"Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis","officialTitle":"A 6-Week Randomized, Double-blind, Placebo-controlled, Parallel Group, Safety Study of the Potential Inhibitory Effects of Ciclesonide Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal (HPA) Axis in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-07","primaryCompletion":"2011-11","completion":"2011-11","firstPosted":"2011-06-22","resultsPosted":"2014-05-26","lastUpdate":"2014-05-26"},"enrollment":89,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Perennial Allergic Rhinitis","PAR"],"interventions":[{"type":"DRUG","name":"ciclesonide nasal aerosol","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"ciclesonide nasal aerosol","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a multicenter, randomized, double-blind, placebo-controlled, parallel group, safety study of the effects of ciclesonide nasal aerosol (74 mcg) on the HPA axis when administered once daily to male and premenarchal female subjects 6 to 11 years of age with a diagnosis of PAR.","primaryOutcome":{"measure":"The Change in Serum Cortisol Area Under the Curve (AUC) From Time 0 to 24 Hours (0-24), Calculated Using a Trapezoidal Rule, From Baseline to the End of the 6 Week Treatment Period","timeFrame":"Week 0 and 6","effectByArm":[{"arm":"Placebo","deltaMin":5.9,"sd":5.6},{"arm":"Ciclesonide Nasal Aerosol","deltaMin":-1.7,"sd":5.2}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":18},"locations":{"siteCount":7,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":42},"commonTop":["Headache","Oropharyngeal pain"]}}